CinqueP, KoralnikIJ, GereviniS, et al. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis, 2009; 9:625–636.
2.
EngsigFN, HansenAB, OmlandLH, et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: A nationwide cohort study. J Infect Dis, 2009; 199:77–83.
3.
CliffordDB, YiannoutsosC, GlicksmanM, et al. HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology, 1999; 52:623–625.
4.
FalcóV, OlmoM, del SazSV, et al. Influence of HAART on the clinical course of HIV-1-infected patients with progressive multifocal leukoencephalopathy: Results of an observational multicenter study. J Acquir Immune Defic Syndr, 2008; 49:26–31.
5.
AlbrechtH, HoffmannC, DegenO, et al. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS, 1998; 12:1149–1154.
6.
KhannaN, ElziL, MuellerNJ, et al. Incidence and outcome of progressive multifocal leukoencephalopathy over 20 years of the Swiss HIV Cohort Study. Clin Infect Dis, 2009; 48:1459–1466.
7.
WyenC, LehmannC, FätkenheuerG, et al. AIDS-related progressive multifocal leukoencephalopathy in the era of HAART: Report of two cases and review of the literature. AIDS Patient Care STDs., 2005; 19:486–494.
8.
De LucaA, AmmassariA, PezzottiP, et al. Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: A multicohort analysis. AIDS, 2008; 22:1759–1767.
9.
LimaMA, Bernal-CanoF, CliffordDB, et al. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry, 2010; 81:1288–1291.
10.
OkenMM, CreechRH, TormeyDC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol, 1982; 5:649–655.
11.
BerenguerJ, MirallesP, ArrizabalagaJ, et al. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy. Clin Infect Dis, 2003; 36:1047–1052.
12.
HarrisonDM, NewsomeSD, SkolaskyRL, et al. Immune reconstitution is not a prognostic factor in progressive multifocal leukoencephalopathy. J Neuroimmunol, 2011; 238:81–86.
